Request for Covid-19 Impact Assessment of this Report
The United States Oral Contrast Agent market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Contrast Agent market, reaching US$ million by the year 2028. As for the Europe Oral Contrast Agent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Contrast Agent players cover GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Contrast Agent market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Contrast Agent Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Contrast Agent by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Contrast Agent by Country/Region, 2017, 2022 & 2028
2.2 Oral Contrast Agent Segment by Type
2.2.1 Barium-based Contrast Media
2.2.2 Iodinated Contrast Media
2.2.3 Gadolinium-based Contrast Media
2.2.4 Microbubble Contrast Media
2.3 Oral Contrast Agent Sales by Type
2.3.1 Global Oral Contrast Agent Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Contrast Agent Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Contrast Agent Sale Price by Type (2017-2022)
2.4 Oral Contrast Agent Segment by Application
2.4.1 Cardiovascular Disorders
2.4.2 Cancer
2.4.3 Gastrointestinal Disorders
2.4.4 Musculoskeletal Disorders
2.4.5 Neurological Disorders
2.4.6 Nephrological Disorders
2.5 Oral Contrast Agent Sales by Application
2.5.1 Global Oral Contrast Agent Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Contrast Agent Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Contrast Agent Sale Price by Application (2017-2022)
3 Global Oral Contrast Agent by Company
3.1 Global Oral Contrast Agent Breakdown Data by Company
3.1.1 Global Oral Contrast Agent Annual Sales by Company (2020-2022)
3.1.2 Global Oral Contrast Agent Sales Market Share by Company (2020-2022)
3.2 Global Oral Contrast Agent Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Contrast Agent Revenue by Company (2020-2022)
3.2.2 Global Oral Contrast Agent Revenue Market Share by Company (2020-2022)
3.3 Global Oral Contrast Agent Sale Price by Company
3.4 Key Manufacturers Oral Contrast Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Contrast Agent Product Location Distribution
3.4.2 Players Oral Contrast Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Contrast Agent by Geographic Region
4.1 World Historic Oral Contrast Agent Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Contrast Agent Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Contrast Agent Annual Revenue by Geographic Region
4.2 World Historic Oral Contrast Agent Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Contrast Agent Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Contrast Agent Annual Revenue by Country/Region
4.3 Americas Oral Contrast Agent Sales Growth
4.4 APAC Oral Contrast Agent Sales Growth
4.5 Europe Oral Contrast Agent Sales Growth
4.6 Middle East & Africa Oral Contrast Agent Sales Growth
5 Americas
5.1 Americas Oral Contrast Agent Sales by Country
5.1.1 Americas Oral Contrast Agent Sales by Country (2017-2022)
5.1.2 Americas Oral Contrast Agent Revenue by Country (2017-2022)
5.2 Americas Oral Contrast Agent Sales by Type
5.3 Americas Oral Contrast Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Contrast Agent Sales by Region
6.1.1 APAC Oral Contrast Agent Sales by Region (2017-2022)
6.1.2 APAC Oral Contrast Agent Revenue by Region (2017-2022)
6.2 APAC Oral Contrast Agent Sales by Type
6.3 APAC Oral Contrast Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Contrast Agent by Country
7.1.1 Europe Oral Contrast Agent Sales by Country (2017-2022)
7.1.2 Europe Oral Contrast Agent Revenue by Country (2017-2022)
7.2 Europe Oral Contrast Agent Sales by Type
7.3 Europe Oral Contrast Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Contrast Agent by Country
8.1.1 Middle East & Africa Oral Contrast Agent Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Contrast Agent Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Contrast Agent Sales by Type
8.3 Middle East & Africa Oral Contrast Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Contrast Agent
10.3 Manufacturing Process Analysis of Oral Contrast Agent
10.4 Industry Chain Structure of Oral Contrast Agent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Contrast Agent Distributors
11.3 Oral Contrast Agent Customer
12 World Forecast Review for Oral Contrast Agent by Geographic Region
12.1 Global Oral Contrast Agent Market Size Forecast by Region
12.1.1 Global Oral Contrast Agent Forecast by Region (2023-2028)
12.1.2 Global Oral Contrast Agent Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Contrast Agent Forecast by Type
12.7 Global Oral Contrast Agent Forecast by Application
13 Key Players Analysis
13.1 GE Healthcare (US)
13.1.1 GE Healthcare (US) Company Information
13.1.2 GE Healthcare (US) Oral Contrast Agent Product Offered
13.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GE Healthcare (US) Main Business Overview
13.1.5 GE Healthcare (US) Latest Developments
13.2 Bracco Imaging (Italy)
13.2.1 Bracco Imaging (Italy) Company Information
13.2.2 Bracco Imaging (Italy) Oral Contrast Agent Product Offered
13.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bracco Imaging (Italy) Main Business Overview
13.2.5 Bracco Imaging (Italy) Latest Developments
13.3 Bayer HealthCare (Germany)
13.3.1 Bayer HealthCare (Germany) Company Information
13.3.2 Bayer HealthCare (Germany) Oral Contrast Agent Product Offered
13.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer HealthCare (Germany) Main Business Overview
13.3.5 Bayer HealthCare (Germany) Latest Developments
13.4 Guerbet (France)
13.4.1 Guerbet (France) Company Information
13.4.2 Guerbet (France) Oral Contrast Agent Product Offered
13.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Guerbet (France) Main Business Overview
13.4.5 Guerbet (France) Latest Developments
13.5 Lantheus (US)
13.5.1 Lantheus (US) Company Information
13.5.2 Lantheus (US) Oral Contrast Agent Product Offered
13.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Lantheus (US) Main Business Overview
13.5.5 Lantheus (US) Latest Developments
13.6 Daiichi Sankyo (Japan)
13.6.1 Daiichi Sankyo (Japan) Company Information
13.6.2 Daiichi Sankyo (Japan) Oral Contrast Agent Product Offered
13.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Daiichi Sankyo (Japan) Main Business Overview
13.6.5 Daiichi Sankyo (Japan) Latest Developments
13.7 Unijules Life Sciences (India)
13.7.1 Unijules Life Sciences (India) Company Information
13.7.2 Unijules Life Sciences (India) Oral Contrast Agent Product Offered
13.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Unijules Life Sciences (India) Main Business Overview
13.7.5 Unijules Life Sciences (India) Latest Developments
13.8 J.B. Chemicals and Pharmaceuticals (India)
13.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
13.8.2 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Offered
13.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 J.B. Chemicals and Pharmaceuticals (India) Main Business Overview
13.8.5 J.B. Chemicals and Pharmaceuticals (India) Latest Developments
13.9 Spago Nanomedicine (Sweden)
13.9.1 Spago Nanomedicine (Sweden) Company Information
13.9.2 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Offered
13.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Spago Nanomedicine (Sweden) Main Business Overview
13.9.5 Spago Nanomedicine (Sweden) Latest Developments
13.10 Taejoon Pharm (South Korea)
13.10.1 Taejoon Pharm (South Korea) Company Information
13.10.2 Taejoon Pharm (South Korea) Oral Contrast Agent Product Offered
13.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Taejoon Pharm (South Korea) Main Business Overview
13.10.5 Taejoon Pharm (South Korea) Latest Developments
13.11 Jodas (India)
13.11.1 Jodas (India) Company Information
13.11.2 Jodas (India) Oral Contrast Agent Product Offered
13.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jodas (India) Main Business Overview
13.11.5 Jodas (India) Latest Developments
13.12 Magnus Health (India)
13.12.1 Magnus Health (India) Company Information
13.12.2 Magnus Health (India) Oral Contrast Agent Product Offered
13.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Magnus Health (India) Main Business Overview
13.12.5 Magnus Health (India) Latest Developments
14 Research Findings and Conclusion
Table 1. Oral Contrast Agent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Contrast Agent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Barium-based Contrast Media
Table 4. Major Players of Iodinated Contrast Media
Table 5. Major Players of Gadolinium-based Contrast Media
Table 6. Major Players of Microbubble Contrast Media
Table 7. Global Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Oral Contrast Agent Sales Market Share by Type (2017-2022)
Table 9. Global Oral Contrast Agent Revenue by Type (2017-2022) & ($ million)
Table 10. Global Oral Contrast Agent Revenue Market Share by Type (2017-2022)
Table 11. Global Oral Contrast Agent Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Oral Contrast Agent Sales Market Share by Application (2017-2022)
Table 14. Global Oral Contrast Agent Revenue by Application (2017-2022)
Table 15. Global Oral Contrast Agent Revenue Market Share by Application (2017-2022)
Table 16. Global Oral Contrast Agent Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Oral Contrast Agent Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Oral Contrast Agent Sales Market Share by Company (2020-2022)
Table 19. Global Oral Contrast Agent Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Oral Contrast Agent Revenue Market Share by Company (2020-2022)
Table 21. Global Oral Contrast Agent Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Oral Contrast Agent Producing Area Distribution and Sales Area
Table 23. Players Oral Contrast Agent Products Offered
Table 24. Oral Contrast Agent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Oral Contrast Agent Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Oral Contrast Agent Sales Market Share Geographic Region (2017-2022)
Table 29. Global Oral Contrast Agent Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Oral Contrast Agent Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Oral Contrast Agent Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Oral Contrast Agent Sales Market Share by Country/Region (2017-2022)
Table 33. Global Oral Contrast Agent Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Oral Contrast Agent Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Oral Contrast Agent Sales Market Share by Country (2017-2022)
Table 37. Americas Oral Contrast Agent Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Oral Contrast Agent Revenue Market Share by Country (2017-2022)
Table 39. Americas Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Oral Contrast Agent Sales Market Share by Type (2017-2022)
Table 41. Americas Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Oral Contrast Agent Sales Market Share by Application (2017-2022)
Table 43. APAC Oral Contrast Agent Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Oral Contrast Agent Sales Market Share by Region (2017-2022)
Table 45. APAC Oral Contrast Agent Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Oral Contrast Agent Revenue Market Share by Region (2017-2022)
Table 47. APAC Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Oral Contrast Agent Sales Market Share by Type (2017-2022)
Table 49. APAC Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Oral Contrast Agent Sales Market Share by Application (2017-2022)
Table 51. Europe Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Oral Contrast Agent Sales Market Share by Country (2017-2022)
Table 53. Europe Oral Contrast Agent Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Oral Contrast Agent Revenue Market Share by Country (2017-2022)
Table 55. Europe Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Oral Contrast Agent Sales Market Share by Type (2017-2022)
Table 57. Europe Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Oral Contrast Agent Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Oral Contrast Agent Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oral Contrast Agent Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Oral Contrast Agent Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Oral Contrast Agent Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Oral Contrast Agent Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Oral Contrast Agent
Table 68. Key Market Challenges & Risks of Oral Contrast Agent
Table 69. Key Industry Trends of Oral Contrast Agent
Table 70. Oral Contrast Agent Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Oral Contrast Agent Distributors List
Table 73. Oral Contrast Agent Customer List
Table 74. Global Oral Contrast Agent Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Oral Contrast Agent Sales Market Forecast by Region
Table 76. Global Oral Contrast Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Oral Contrast Agent Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Oral Contrast Agent Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Oral Contrast Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Oral Contrast Agent Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Oral Contrast Agent Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Oral Contrast Agent Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Oral Contrast Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Oral Contrast Agent Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Oral Contrast Agent Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Oral Contrast Agent Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Oral Contrast Agent Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Oral Contrast Agent Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Oral Contrast Agent Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Oral Contrast Agent Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Oral Contrast Agent Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Oral Contrast Agent Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Oral Contrast Agent Revenue Market Share Forecast by Application (2023-2028)
Table 94. GE Healthcare (US) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 95. GE Healthcare (US) Oral Contrast Agent Product Offered
Table 96. GE Healthcare (US) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. GE Healthcare (US) Main Business
Table 98. GE Healthcare (US) Latest Developments
Table 99. Bracco Imaging (Italy) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 100. Bracco Imaging (Italy) Oral Contrast Agent Product Offered
Table 101. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Bracco Imaging (Italy) Main Business
Table 103. Bracco Imaging (Italy) Latest Developments
Table 104. Bayer HealthCare (Germany) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 105. Bayer HealthCare (Germany) Oral Contrast Agent Product Offered
Table 106. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Bayer HealthCare (Germany) Main Business
Table 108. Bayer HealthCare (Germany) Latest Developments
Table 109. Guerbet (France) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 110. Guerbet (France) Oral Contrast Agent Product Offered
Table 111. Guerbet (France) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Guerbet (France) Main Business
Table 113. Guerbet (France) Latest Developments
Table 114. Lantheus (US) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 115. Lantheus (US) Oral Contrast Agent Product Offered
Table 116. Lantheus (US) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Lantheus (US) Main Business
Table 118. Lantheus (US) Latest Developments
Table 119. Daiichi Sankyo (Japan) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 120. Daiichi Sankyo (Japan) Oral Contrast Agent Product Offered
Table 121. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. Daiichi Sankyo (Japan) Main Business
Table 123. Daiichi Sankyo (Japan) Latest Developments
Table 124. Unijules Life Sciences (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 125. Unijules Life Sciences (India) Oral Contrast Agent Product Offered
Table 126. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 127. Unijules Life Sciences (India) Main Business
Table 128. Unijules Life Sciences (India) Latest Developments
Table 129. J.B. Chemicals and Pharmaceuticals (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 130. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Offered
Table 131. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 132. J.B. Chemicals and Pharmaceuticals (India) Main Business
Table 133. J.B. Chemicals and Pharmaceuticals (India) Latest Developments
Table 134. Spago Nanomedicine (Sweden) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 135. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Offered
Table 136. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 137. Spago Nanomedicine (Sweden) Main Business
Table 138. Spago Nanomedicine (Sweden) Latest Developments
Table 139. Taejoon Pharm (South Korea) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 140. Taejoon Pharm (South Korea) Oral Contrast Agent Product Offered
Table 141. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 142. Taejoon Pharm (South Korea) Main Business
Table 143. Taejoon Pharm (South Korea) Latest Developments
Table 144. Jodas (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 145. Jodas (India) Oral Contrast Agent Product Offered
Table 146. Jodas (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 147. Jodas (India) Main Business
Table 148. Jodas (India) Latest Developments
Table 149. Magnus Health (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 150. Magnus Health (India) Oral Contrast Agent Product Offered
Table 151. Magnus Health (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 152. Magnus Health (India) Main Business
Table 153. Magnus Health (India) Latest Developments
List of Figures
Figure 1. Picture of Oral Contrast Agent
Figure 2. Oral Contrast Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Contrast Agent Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Oral Contrast Agent Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Contrast Agent Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Barium-based Contrast Media
Figure 10. Product Picture of Iodinated Contrast Media
Figure 11. Product Picture of Gadolinium-based Contrast Media
Figure 12. Product Picture of Microbubble Contrast Media
Figure 13. Global Oral Contrast Agent Sales Market Share by Type in 2021
Figure 14. Global Oral Contrast Agent Revenue Market Share by Type (2017-2022)
Figure 15. Oral Contrast Agent Consumed in Cardiovascular Disorders
Figure 16. Global Oral Contrast Agent Market: Cardiovascular Disorders (2017-2022) & (K Pcs)
Figure 17. Oral Contrast Agent Consumed in Cancer
Figure 18. Global Oral Contrast Agent Market: Cancer (2017-2022) & (K Pcs)
Figure 19. Oral Contrast Agent Consumed in Gastrointestinal Disorders
Figure 20. Global Oral Contrast Agent Market: Gastrointestinal Disorders (2017-2022) & (K Pcs)
Figure 21. Oral Contrast Agent Consumed in Musculoskeletal Disorders
Figure 22. Global Oral Contrast Agent Market: Musculoskeletal Disorders (2017-2022) & (K Pcs)
Figure 23. Oral Contrast Agent Consumed in Neurological Disorders
Figure 24. Global Oral Contrast Agent Market: Neurological Disorders (2017-2022) & (K Pcs)
Figure 25. Oral Contrast Agent Consumed in Nephrological Disorders
Figure 26. Global Oral Contrast Agent Market: Nephrological Disorders (2017-2022) & (K Pcs)
Figure 27. Global Oral Contrast Agent Sales Market Share by Application (2017-2022)
Figure 28. Global Oral Contrast Agent Revenue Market Share by Application in 2021
Figure 29. Oral Contrast Agent Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Oral Contrast Agent Revenue Market Share by Company in 2021
Figure 31. Global Oral Contrast Agent Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Oral Contrast Agent Revenue Market Share by Geographic Region in 2021
Figure 33. Global Oral Contrast Agent Sales Market Share by Region (2017-2022)
Figure 34. Global Oral Contrast Agent Revenue Market Share by Country/Region in 2021
Figure 35. Americas Oral Contrast Agent Sales 2017-2022 (K Pcs)
Figure 36. Americas Oral Contrast Agent Revenue 2017-2022 ($ Millions)
Figure 37. APAC Oral Contrast Agent Sales 2017-2022 (K Pcs)
Figure 38. APAC Oral Contrast Agent Revenue 2017-2022 ($ Millions)
Figure 39. Europe Oral Contrast Agent Sales 2017-2022 (K Pcs)
Figure 40. Europe Oral Contrast Agent Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Oral Contrast Agent Sales 2017-2022 (K Pcs)
Figure 42. Middle East & Africa Oral Contrast Agent Revenue 2017-2022 ($ Millions)
Figure 43. Americas Oral Contrast Agent Sales Market Share by Country in 2021
Figure 44. Americas Oral Contrast Agent Revenue Market Share by Country in 2021
Figure 45. United States Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Oral Contrast Agent Sales Market Share by Region in 2021
Figure 50. APAC Oral Contrast Agent Revenue Market Share by Regions in 2021
Figure 51. China Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Oral Contrast Agent Sales Market Share by Country in 2021
Figure 58. Europe Oral Contrast Agent Revenue Market Share by Country in 2021
Figure 59. Germany Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Oral Contrast Agent Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Oral Contrast Agent Revenue Market Share by Country in 2021
Figure 66. Egypt Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Oral Contrast Agent in 2021
Figure 72. Manufacturing Process Analysis of Oral Contrast Agent
Figure 73. Industry Chain Structure of Oral Contrast Agent
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...